Cargando…

Oncocytic-type intraductal papillary mucinous neoplasm (IPMN)-derived invasive oncocytic pancreatic carcinoma with brain metastasis - a case report

Pancreatic cancer is a lethal disease without effective treatments at present. It ranks as s as 4(th) and 5(th) in cancer-related mortality in the western countries and worldwide. Locally advanced pancreatic duct carcinoma (PDAC) and metastatic PDAC, usually found the metastases over liver, peritone...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Kun-Chun, Yu, Chi-Chang, Chen, Jim-Ray, Huang, Yu-Ting, Huang, Cheng-Cheng, Yeh, Chun-Nan, Tsai, Chien-Sheng, Chen, Li-Wei, Chen, Hsien-Cin, Hsu, Jun-Te, Wang, Cheng-Hsu, Chen, Huang-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488575/
https://www.ncbi.nlm.nih.gov/pubmed/22776211
http://dx.doi.org/10.1186/1477-7819-10-138
Descripción
Sumario:Pancreatic cancer is a lethal disease without effective treatments at present. It ranks as s as 4(th) and 5(th) in cancer-related mortality in the western countries and worldwide. Locally advanced pancreatic duct carcinoma (PDAC) and metastatic PDAC, usually found the metastases over liver, peritoneum, or lung, have been shown to be with dismal prognosis. Brain metastasis is a rare entity and most cases reported before were found post-mortem. Intraductal papillary mucinous neoplasms of the pancreas (IPMN) has been deemed as a precursor of PDAC with very slow progression rate. Here we reported a case diagnosed with IPMN-derived PDAC with brain metastasis. After surgeries for PDAC and brain metastasis, subsequent chemotherapy and radiotherapy were also given. One and half year after surgery, this patient is still living with good performance status, which may warrant individualization of therapeutic strategy for PDAC with only brain metastasis.